YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$3.14
+0.16%Next report
Analyst consensus
- Next report date
- Nov 26, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 17, 2026
- EPS actual
- -$0.60
- EPS estimate
- —
- Revenue actual
- $338.5M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 17, 2026 | — | -$0.60 | — | $338.5M |
| Jun 4, 2026 | — | -$0.60 | — | $342.3M |
| Dec 17, 2025 | — | -$0.20 | — | $421.5M |
| Sep 17, 2025 | — | -$0.40 | — | $447.0M |
| Jun 19, 2025 | — | -$0.20 | — | $484.7M |
| Mar 20, 2025 | — | -$0.04 | — | $527.0M |
| Nov 27, 2024 | — | -$0.20 | — | $513.1M |
| Aug 29, 2024 | — | -$0.20 | — | $471.2M |
| May 23, 2024 | — | -$0.20 | — | $487.8M |
| Mar 21, 2024 | — | -$3.40 | — | $580.1M |
| Nov 30, 2023 | — | -$1.60 | — | $501.7M |
| Aug 24, 2023 | — | -$1.00 | — | $480.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 26, 2026